43
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

, , &
Pages 1751-1758 | Published online: 09 Dec 2011

References

  • RogersSMcIntoshRLCheungNThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaOphthalmology2010117231331920022117
  • Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study GroupAm J Ophthalmol19849832712826383055
  • McIntoshRLMohamedQSawSMWongTYInterventions for branch retinal vein occlusion: an evidence-based systematic reviewOphthalmology2007114583585417397923
  • Wilkinson-BerkaJLMillerAGUpdate on the treatment of diabetic retinopathyScientific World Journal200889812018264628
  • SchachatAPA new approach to the management of diabetic macular edemaOphthalmology201011761059106020522333
  • MohamedQMcIntoshRLSawSMWongTYInterventions for central retinal vein occlusion: an evidence-based systematic reviewOphthalmology2007114350751917324695
  • KariaNRetinal vein occlusion: pathophysiology and treatment optionsClin Ophthalmol2010480981620689798
  • HallerJABandelloFBelfortRJrRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology201011761134114620417567
  • IpMSScottIUVan VeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol200912791101111419752419
  • ScottIUIpMSVan VeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol200912791115112819752420
  • BrownDMCampochiaroPASinghRPRanibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology201011761124113320381871
  • CampochiaroPAHeierJSFeinerLRanibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology201011761102111220398941
  • SivaprasadSMcCluskeyPLightmanSIntravitreal steroids in the management of macular oedemaActa Ophthalmol Scand200684672273317083528
  • PieramiciDJRabenaMDAnti-VEGF therapy: comparison of current and future agentsEye (Lond)200822101330133618497829
  • IpMKahanaAAltaweelMTreatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography studySemin Ophthalmol2003182677314566625
  • ParkCHJaffeGJFekratSIntravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusionAm J Ophthalmol2003136341942512967793
  • BashshurZFMalufRNAllamSJurdiFAHaddadRSNoureddinBNIntravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusionArch Ophthalmol200412281137114015302653
  • IpMSGottliebJLKahanaAIntravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusionArch Ophthalmol200412281131113615302652
  • AstamNBatiogluFOzmertEShort-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusionInt Ophthalmol200929534334818553061
  • GroverDLiTJChongCCIntravitreal steroids for macular edema in diabetesCochrane Database Syst Rev20081CD00565618254088
  • GunduzKBakriSJIntravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusionEye (Lond)20082291168117118344969
  • HauserDBukelmanAPokroyRIntravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mgRetina200828682583018536598
  • YilmazTWeaverCDGallagherMJIntravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic reviewOphthalmology2009116590291119410949
  • JermakCMDellacroceJTHeffezJPeymanGATriamcinolone acetonide in ocular therapeuticsSurv Ophthalmol200752550352217719372
  • AhmadiehHRamezaniAShoeibiNIntravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trialGraefes Arch Clin Exp Ophthalmol2008246448348917917738
  • Diabetic Retinopathy Clinical Research NetworkA randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edemaOphthalmology200811591447144918662829
  • BeckRWEdwardsARAielloLPThree-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edemaArch Ophthalmol2009127324525119273785
  • ElmanMJAielloLPBeckRWRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology201011761064107720427088
  • SoheilianMRamezaniABijanzadehBIntravitreal bevacizumab (Avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edemaRetina20072791187119518046223
  • BrowningDJGlassmanARAielloLPOptical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edemaOphthalmology200811581366137118675696
  • MarmorMFMarmorMFWolfensbergerTJControl of subretinal fluid and mechanisms of serous detachmentThe Retinal Pigment Epithelium: Function and DiseaseNew York, NYOxford University Press1998
  • KosobuckiBRFreemanWRChengLPhotographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eyeBr J Ophthalmol200690670570816531422
  • JonasJBIntraocular availability of triamcinolone acetonide after intravitreal injectionAm J Ophthalmol2004137356056215013884
  • KrohneTUEterNHolzFGMeyerCHIntraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humansAm J Ophthalmol2008146450851218635152
  • BrowningDJGlassmanARAielloLPRelationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edemaOphthalmology2007114352553617123615
  • BlumenkranzMSHallerJAKuppermannBDCorrelation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edemaRetina20103071090109420616686
  • KhuranaRNDoDVNguyenQDAnti-VEGF therapeutic approaches for diabetic macular edemaInt Ophthalmol Clin200949210911919349791
  • ScottIUEdwardsARBeckRWA phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edemaOphthalmology2007114101860186717698196
  • KiernanDFHariprasadSMChinEKKiernanCLRagoJMielerWFProspective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thicknessAm J Ophthalmol2009147226727518929353